SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 115 filers reported holding SUTRO BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82,440 | -78.3% | 23,758 | -70.9% | 0.00% | -100.0% |
| Q2 2023 | $379,910 | -79.1% | 81,701 | -79.2% | 0.00% | -75.0% |
| Q1 2023 | $1,818,876 | +13.6% | 393,696 | +98.7% | 0.00% | 0.0% |
| Q4 2022 | $1,600,696 | +50.2% | 198,106 | +3.1% | 0.00% | +33.3% |
| Q3 2022 | $1,066,000 | +245.0% | 192,076 | +223.4% | 0.00% | +200.0% |
| Q2 2022 | $309,000 | +61.8% | 59,397 | +156.3% | 0.00% | – |
| Q1 2022 | $191,000 | -30.3% | 23,176 | +59.6% | 0.00% | -100.0% |
| Q3 2021 | $274,000 | -71.8% | 14,519 | -66.0% | 0.00% | -50.0% |
| Q1 2021 | $971,000 | +197.9% | 42,670 | +184.3% | 0.00% | +100.0% |
| Q4 2020 | $326,000 | – | 15,009 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |